Nov 1, 2022 November is Crohn’s & Colitis Awareness Month, and We Need Your Help Learn moreEn savoir plus
Oct 20, 2022 Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease Learn moreEn savoir plus
Oct 13, 2022 Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada Learn moreEn savoir plus
Sep 30, 2022 Today, September 30, Marks the Second National Day for Truth and Reconciliation in Canada Learn moreEn savoir plus